Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2025

BackgroundIndividuals diagnosed with type 2 diabetes mellitus (T2DM) commonly exhibit elevated lipid levels and an increased body mass index (BMI). The impact of BMI on the efficacy of statins in reducing lipid levels among diabetic patients remains uncertain.

BMI 52

BMI Diabetes Obesity Outpatient 52

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

The primary objective was to understand the association between body mass index (BMI) and heart failure with reduced ejection fraction (HFREF) of ischemic etiology in outpatients, using mortality as a parameter. 56–70), BMI 18.5–24.9 = 35.1%, 24.9 = 35.1%, 25–29.9 = 37.2%, 30–34.9 = 17.8%, 35–39.9 = 7%; BMI <18.5

Outpatient 59

Outpatient Obesity Heart Failure BMI 59

Circulation

JANUARY 22, 2025

Current consensus age- and BMI-stratified rule-in thresholds demonstrated only 65% specificity (95% CI, 57%72%). With a BMI 35 kg/m2, lower rule-in thresholds (220 pg/mL) provided good specificity (88% [95% CI, 73%100%]; 93% [95% CI, 81%100%] and 100% in validation cohorts).

Preserved Ejection Fraction 55

Preserved Ejection Fraction Outpatient Heart Failure BMI 55

DAIC

MARCH 27, 2025

PET is the most effective form of MPI for detecting CAD iii and is recommended for a wide range of patients, including those considered more challenging to diagnose, such as individuals with a BMI greater than 30 or women, especially those with dense breastsi v , over SPECT MPI.

Coronary Artery Disease 52

Coronary Artery Disease CMS Innovation Ischemia 52

European Journal of Heart Failure

DECEMBER 18, 2024

Association between body mass index (BMI) and clinical outcomes in PARADISE-MI. ( A ) Histogram for BMI (kg/m 2 ), ( B ) adverse events for BMI subgroups, and spline model curves for ( C ) the primary composite outcome and ( D ) cardiovascular (CV) death by BMI subgroups. 100 patient-years for BMI 40kg/m 2 ).

Myocardial Infarction 40

Myocardial Infarction BMI Outcomes Heart Failure 40

Circulation

NOVEMBER 11, 2024

Effect sizes presented based on between groups ANOVA.Results:There were no differences between groups for baseline age, BMI, sex, FMD%, PWV, mMRC, 6MWD and inspiratory muscle strength. An ANOVA was applied using the intention-to-treat analysis. Data are expressed in mean±SD. post = 340.4 ± 36.6 post = 1.6 ± 0.6 post = 68.8 ± 13.6

Cardiac Rehabilitation 40

Cardiac Rehabilitation Heart Disease BMI Outpatient 40